These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2319521)

  • 1. Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations.
    Ward MM; Studenski S
    J Rheumatol; 1990 Feb; 17(2):220-4. PubMed ID: 2319521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis.
    Ward MM; Studenski S
    J Rheumatol; 1990 Apr; 17(4):476-81. PubMed ID: 2348426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
    Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
    Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
    Mikdashi J; Krumholz A; Handwerger B
    Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in the clinical and serological features of systemic lupus erythematosus in Malaysian patients.
    Azizah MR; Ainol SS; Kong NC; Normaznah Y; Rahim MN
    Med J Malaysia; 2001 Sep; 56(3):302-7. PubMed ID: 11732074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?
    Ward MM
    J Rheumatol; 2002 Jun; 29(6):1198-206. PubMed ID: 12064835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.
    Ward MM; Pyun E; Studenski S
    Arch Intern Med; 1996 Jun; 156(12):1337-44. PubMed ID: 8651844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between familial and sporadic systemic lupus erythematosus in Kuwaiti patients.
    Abutiban F; Mokkaddam K; Ameen E; Moussa M; Alsaeid K
    Lupus; 2009 Jan; 18(1):86-91. PubMed ID: 19074175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus disease severity in men and women: a case-control study.
    Aranow C; Del Guidice J; Barland P; Weinstein A
    J Rheumatol; 2002 Aug; 29(8):1674-7. PubMed ID: 12180728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familiality and co-occurrence of clinical features of systemic lupus erythematosus.
    Tsao BP; Grossman JM; Riemekasten G; Strong N; Kalsi J; Wallace DJ; Chen CJ; Lau CS; Ginzler EM; Goldstein R; Kalunian KC; Harley JB; Arnett FC; Hahn BH; Cantor RM
    Arthritis Rheum; 2002 Oct; 46(10):2678-85. PubMed ID: 12384927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease.
    Bertoli AM; Alarcón GS; Calvo-Alén J; Fernández M; Vilá LM; Reveille JD;
    Arthritis Rheum; 2006 May; 54(5):1580-7. PubMed ID: 16645994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM
    Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
    Bruce IN; Hallett DC; Gladman DD; Urowitz MB
    J Rheumatol; 1999 Jul; 26(7):1490-4. PubMed ID: 10405935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
    Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
    Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation.
    Massardo L; Metz C; Pardo E; Mezzano V; Babul M; Jarpa E; Guzmán AM; André S; Kaltner H; Gabius HJ; Jacobelli S; González A; Soza A
    Lupus; 2009 May; 18(6):539-46. PubMed ID: 19395456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.
    Cervera R; Khamashta MA; Font J; Sebastiani GD; Gil A; Lavilla P; Doménech I; Aydintug AO; Jedryka-Góral A; de Ramón E
    Medicine (Baltimore); 1993 Mar; 72(2):113-24. PubMed ID: 8479324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with active systemic lupus erythematosus after endstage renal disease.
    Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
    J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.